Ultimate Longevity Bible

Biomarker

Non-HDL Cholesterol

Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

ObservationalBetter than LDL-C alone, weaker than apoB

What it measures

Non-HDL cholesterol = total cholesterol − HDL-C. It captures the cholesterol in all atherogenic particles (LDL + IDL + VLDL + remnants), not just LDL. Because it doesn’t depend on the Friedewald calculation, it remains accurate when triglycerides are elevated.

When to use it

  • When apoB testing isn’t available, non-HDL is the next-best proxy.
  • When LDL-C is unreliable (high triglycerides, post-meal sample).
  • In children and adolescents where non-HDL may be more stable than LDL-C.

Targets

Generally LDL-C target + 30 mg/dL:

  • Primary prevention: <130 mg/dL.
  • Diabetes / multiple risk factors: <100 mg/dL.
  • Established ASCVD: <85 mg/dL.

Limitations

Non-HDL still measures cholesterol mass, not particle count. Same discordance with apoB exists when small dense LDL predominates — just less than with LDL-C.

Related entries

ApoB, LDL-C, Triglycerides.

References

  • Sniderman, A. D. et al. Non-HDL cholesterol versus apolipoprotein B in cardiovascular risk stratification. JAMA 309, 2103–2110 (2013).

More biomarkers